Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.55M.
ENTERPRISE VALUE (EV)
$2.55M
60 Degrees Pharmaceuticals, Inc.
Market Cap
$3.90M
Enterprise Value (EV)
$2.55M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | $3.90M | $2.55M |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.93M | N/A |
| GRI Bio, Inc. (GRI)vs › | $4.15M | N/A |
| Evogene Ltd. (EVGN)vs › | $3.65M | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.65M | N/A |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.63M | $7.00M |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.21M | $4.01M |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.53M | $1.14M |
| Moolec Science S.A. (MLEC)vs › | $3.50M | N/A |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A |
Market Cap
$3.90M
Total Debt
$152775.00
Cash
$1.51M
Enterprise Value
$2.55M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
